Skip to main content

1 Result(s)

within English Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter Yoshimasa Shiraishi Remove this filter

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer

Include preview-only content

  1. Article

    Open Access

    Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

    Erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), and bevacizumab, an anti-vascular endothelial growth factor (VEGF) agent, are promising therapies for advanced non-small c...

    Heyan Li, Koichi Takayama, Shuo Wang… in Cancer Chemotherapy and Pharmacology (2014)

    Download PDF (2896 KB) View Article